GALNS rs948490589: What Your Genotype Means
The rs948490589 variant is a specific change within the GALNS gene that is identified as a carrier mutation for Mucopolysaccharidosis type IV-A, also known as Morquio A syndrome. This condition is an autosomal recessive lysosomal storage disorder that affects how the body breaks down certain sugar molecules.
What each genotype means
Typical GALNS genotype
This genotype represents the common, expected sequence for the GALNS gene at this location. It is not associated with the carrier status for Mucopolysaccharidosis type IV-A (Morquio syndrome).
This is the most common genotype found in the general population.
Carrier of Morquio syndrome
This genotype indicates you are a carrier of a variant associated with Mucopolysaccharidosis type IV-A (Morquio syndrome). Carriers are typically unaffected by the condition, as it is an autosomal recessive disorder that generally requires two pathogenic mutations to manifest symptoms.
This genotype is rare in the general population.
Potential Morquio syndrome risk
This genotype indicates the presence of the variant on both copies of the GALNS gene. Because this variant is linked to Mucopolysaccharidosis type IV-A, individuals with this result should consult with a medical geneticist or healthcare provider to discuss clinical implications and potential diagnostic testing.
This genotype is extremely rare in the general population.
Understanding the SNP and Its Location
The variant rs948490589 is a single nucleotide polymorphism (SNP) located on chromosome 16 within the GALNS gene. In genetics, a SNP represents a variation at a single position in a DNA sequence among individuals. This specific variant is cataloged in major genomic databases, including dbSNP, and is recognized for its clinical relevance regarding carrier status. Because it is located within the coding region of the GALNS gene, it has the potential to alter the instructions for the protein that the gene produces. Researchers track such variants to understand their impact on human health and their distribution across different populations.
The Role of the GALNS Gene
The GALNS gene provides the essential instructions for producing an enzyme called N-acetylgalactosamine-6-sulfatase. This enzyme functions within lysosomes, which are the recycling centers of the cell. Its primary job is to break down complex sugar molecules known as glycosaminoglycans (GAGs), specifically keratan sulfate. Keratan sulfate is a critical component of cartilage and the cornea of the eye. When the GALNS enzyme is missing or not functioning correctly, these sugar molecules cannot be properly broken down and recycled. Instead, they accumulate within the lysosomes, which can interfere with normal cellular function and lead to the skeletal and connective tissue abnormalities characteristic of Morquio A syndrome.
Research and Clinical Significance
Mucopolysaccharidosis type IV-A (MPS IVA) is an autosomal recessive disorder, meaning that an individual typically needs to inherit two copies of a pathogenic variant—one from each parent—to manifest the condition. The rs948490589 variant is identified as a carrier mutation. Being a carrier means an individual has one copy of the variant and one functional copy of the gene, which is generally sufficient for the body to produce enough enzyme to avoid the symptoms of the disorder. Research into GALNS variants is extensive because there are many different mutations that can lead to MPS IVA. The evidence for this specific variant's role as a carrier mutation is considered moderate, and it is important to note that clinical presentation depends on the presence of a second, potentially different, mutation in the same gene.
What You Can and Cannot Do With This Information
Genetic information regarding carrier status is primarily used for family planning and understanding personal health risks. If you have received results indicating you are a carrier for a GALNS variant, it does not mean you have or will develop Morquio A syndrome. However, it does mean there is a possibility of passing the variant to your children. If both parents are carriers of a pathogenic GALNS variant, there is a statistical chance that a child could inherit two copies and be affected by the condition. This information should not be used for self-diagnosis or to make medical decisions without professional guidance. If you are concerned about your carrier status or family history, you should consult with a certified genetic counselor or a medical geneticist who can provide context based on your specific health history and family background.
How common is this variant?
The rs948490589 variant is considered rare in the general population, with its frequency varying across different ancestral groups.
Frequently asked questions
What is Morquio A syndrome?
Morquio A syndrome, or Mucopolysaccharidosis type IV-A, is a rare genetic disorder that prevents the body from breaking down keratan sulfate. This leads to the accumulation of these sugars in tissues, causing skeletal abnormalities and other health issues.
Does being a carrier mean I have the disease?
No, being a carrier for an autosomal recessive condition like Morquio A syndrome typically means you have one copy of the variant and one normal copy of the gene. Carriers generally do not show symptoms of the disorder.
How is this variant inherited?
This variant is inherited in an autosomal recessive pattern. This means that for a child to be affected, they would need to inherit a pathogenic variant from both parents.
Should I be worried if I am a carrier?
Being a carrier is common for many genetic variants and does not usually impact your own health. If you are planning a family, you may want to speak with a genetic counselor to understand the risks and options available to you.
Sources & further reading
Educational information only, last refreshed 9/24/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs948490589?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GALNS
This variant serves as a carrier marker for Mucopolysaccharidosis type IV-A, a lysosomal storage disorder.
This variant is a pathogenic mutation linked to carrier status for Mucopolysaccharidosis type IV-A.
This variant is identified as a carrier mutation for Mucopolysaccharidosis type IV-A.
This variant is associated with carrier status for Mucopolysaccharidosis type IV-A (MPS-IV-A).